Orthofix Medical（納斯達克股票代碼：OFIX）報告其季度每股收益爲 $0.02，高於分析師預期的 $(0.05)，此次業績超出預期140%。與去年同期的每股虧損 $(0.59) 相比，實現了 103.39% 的增長。公司報告季度銷售額爲 $2.1566億，高於分析師預期的 $2.1271億，提高了 1.38%。與去年同期的銷售額 $2.0041億 相比，增長了 7.61%。

以上內容來自Benzinga Earnings專欄，原文如下：

Orthofix Medical (NASDAQ:OFIX) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.05) by 140 percent. This is a 103.39 percent increase over losses of $(0.59) per share from the same period last year. The company reported quarterly sales of $215.66 million which beat the analyst consensus estimate of $212.71 million by 1.38 percent. This is a 7.61 percent increase over sales of $200.41 million the same period last year.